FDA Considering Biosimilars ‘Guardrails’

US Agency May Take Steps To Prevent Misinformation In Communications

 
• By Sue Sutter
Guardrail_Road
Communications about biosimilars may require some guardrails • Source: Shutterstock

More from Biosimilars

More from Products